Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-010098
Filing Date
2021-01-15
Accepted
2021-01-15 16:21:23
Documents
11
Effectiveness Date
2021-01-15

Document Format Files

Seq Description Document Type Size
1 S-8 d35302ds8.htm S-8 66018
2 EX-5.1 d35302dex51.htm EX-5.1 51877
3 EX-23.2 d35302dex232.htm EX-23.2 1928
4 EX-99.1 d35302dex991.htm EX-99.1 81546
5 EX-99.3 d35302dex993.htm EX-99.3 167941
6 EX-99.4 d35302dex994.htm EX-99.4 118726
7 EX-99.5 d35302dex995.htm EX-99.5 122300
8 EX-99.6 d35302dex996.htm EX-99.6 124106
9 GRAPHIC g35302g0115030925156.jpg GRAPHIC 2878
10 GRAPHIC g35302page68.jpg GRAPHIC 3377
11 GRAPHIC g35302page83a.jpg GRAPHIC 3173
  Complete submission text file 0001193125-21-010098.txt   748902
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-252147 | Film No.: 21532353
SIC: 2834 Pharmaceutical Preparations